Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The Doral Clinic Takeaway: What You Are Actually Paying for at $445 The $445 entry point for CJC-1295/Ipamorelin at Perfect B is not just a peptide purchase
announced the decision to discontinue the development of danuglipron (PF-06882961), an oral glucagon-like peptide-1 (GLP-1) receptor agonist, which was being investigated for chronic weight management
The trial established the IGF-1 axis as a clinical therapeutic target and supports the broader pharmacological rationale for IGF-1 receptor agonism, of which IGF-1 LR3 is one analog with extended pharmacokinetic properties
58 BW was significantly reduced (up to 4.9% placebo-adjusted, p=0.013) over 4 weeks
4 Although many GLP-1 receptor agonists are available, only a few are specifically approved by the FDA for weight management, which has helped relieve some product shortages
Habegger KM, Heppner KM, Geary N, Bartness TJ, DiMarchi R, Tschp MH
US$ 28.37
US$ 29.58
US$ 26.30
US$ 23.12
US$ 21.22
US$ 27.91
US$ 26.72
